Clinical trial
Study of Flavocoxid (Limbrel) vs Naproxen in Subjects With Mod-Severe…
NCT00435292 · Primus Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00435292 |
|---|---|
| Title | Study of Flavocoxid (Limbrel) vs Naproxen in Subjects With Mod-Severe Osteoarthritis of the Knee |
| Official title | A Double-Blind, Randomized, Placebo Controlled, Parallel Group, Multi Center Study of Flavocoxid ( Limbrel) vs Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee |
| Lead sponsor | Primus Pharmaceuticals, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Dietary Supplement, Drug |
| Interventions | Naproxen, flavocoxid 250 mg, flavocoxid 500 mg |
| Enrollment | 350 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Feb 14, 2007 |
| Last update posted | Oct 21, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: